How Common Is Lung Cancer?
Lung cancer is the second most common type of cancer affecting men and women in the United States, excluding skin
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Lung cancer is the second most common type of cancer affecting men and women in the United States, excluding skin
Hematologic oncology is a medical specialty concerned with treating cancers of the blood and blood-forming tissues. Specialists in this field
Smoking is the leading risk factor for lung cancer, and is associated with nearly 90 percent of all cases in
When people receive a lung cancer diagnosis, their oncologists will often recommend that they make certain lifestyle changes to reduce
Being diagnosed with hemophilia can require an adjustment – but people with the condition can still have a full life
A patient’s first mammogram can be an anxiety- and stress-inducing event. However, you can alleviate these feelings by becoming educated
The blood plays an important role in overall health. One of the many functions of blood is to carry oxygen
While it’s normal for people to experience changes in their bowel movements from time to time, frequent or persistent discomfort
A reputation for excellence requires commitment to dedication, long hours, compassion and the motivation to excel.
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.